Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy - sprookjes - yvandenbroek - TriplyDB

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy

http://www.wikidata.org/entity/Q33687218

about

Targeted nanotechnology for cancer imaging.Radioactive Nanomaterials for Multimodality Imaging Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics.In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected]Surfactant-Templated Synthesis of Polypyrrole Nanocages as Redox Mediators for Efficient Energy Storage.In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.Inherently stealthy and highly tumor-selective gold nanoraspberries for photothermal cancer therapy.Biodegradable and Renal Clearable Inorganic Nanoparticles.Radio-nanomaterials for biomedical applications: state of the art Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents.Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles.Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.Ultrafast Synthesis of Multifunctional Submicrometer Hollow Silica Spheres in Microfluidic Spiral Channels Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions.Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres.Enhanced Fluorescence Imaging and Photodynamic Cancer Therapy Using Hollow Mesoporous Nanocontainers.Quantitative and correlative biodistribution analysis of 89Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing mice.Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.Extended Lifetime In Vivo Pulse Stimulated Ultrasound Imaging.Intratumoral H2O2-triggered release of CO from a metal carbonyl-based nanomedicine for efficient CO therapy.Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo.Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances A versatile stimulus-responsive metal–organic framework for size/morphology tunable hollow mesoporous silica and pH-triggered drug delivery MnO-gated Nanoplatforms with Targeted Controlled Drug Release and Contrast-Enhanced MRI Properties: from 2D Cell Culture to 3D Biomimetic Hydrogels General synthesis of silica-based yolk/shell hybrid nanomaterials and tumor vasculature targeting In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem

P2860

Q27010317-BCAE8B37-5712-4EF7-A784-D3D4D1B4B0FF Q28833646-9DD117FB-A7B2-4A0D-90D6-A4A380AF3DC8 Q33594253-828435CD-E6F0-4BAE-926E-9608FD6A503E Q33594333-DC7FCEB2-B99C-4BB9-8747-6A4E50CBF73C Q33830003-7AAC4D17-DD00-4B10-A622-9244F24D8D1B Q35554806-0D4E6FD0-F975-467A-B830-3370FD42CFFC Q35602386-42DCB044-2711-4171-A56F-BB569556E553 Q35856410-443D8E3D-82DD-47EF-AF99-057B9ECA069E Q36064550-BA65484A-4F7C-4782-99A3-E63DFAD9B123 Q36094945-CE00E111-BB83-4105-B4BF-4D2917CE810C Q36293954-02B8D868-2EC9-4C10-A1C2-3F4868371B42 Q37094877-1D3265AB-0484-469B-A5DB-A4A190398A60 Q37131224-5B6716D2-AD00-40C1-B69E-9CCF23521B84 Q38269215-C63CFFDE-66CF-46C8-B085-26EE726684B2 Q38665073-86C5948C-BC00-4E7E-9D4F-1E048A78987A Q38818714-D9D609DD-3D3C-434B-88C5-D973C77DC47D Q38926681-6F22D36F-D17B-42F6-90B7-B26EB9C93BD0 Q39104249-75BDAC4B-B5E4-4F46-847B-05D822FB6CB5 Q41239757-D27601A2-C074-4003-984B-FCF0B3D73426 Q42282482-41B96F52-67C7-4263-ADD4-6F9B8C97EC87 Q42339161-08B95DCB-4BCF-46D5-B134-D948E3320FF9 Q47161512-6E9A35E9-D609-4D0F-9653-D1DD375185F8 Q47228803-8934A25E-E589-4361-8174-A3E7125E888B Q47295411-5AB73FF6-4EC2-416E-81E6-488393EB1515 Q48128797-AC1E7326-7C9C-4961-8438-AF35227CC52D Q48208371-58034B30-8134-4D72-82EA-72504F657C95 Q48211125-77F0A307-E627-4210-8407-743EC1C9BFDE Q48272615-501566F7-CF58-478B-A4D7-4143D22928D0 Q50498752-01FF8253-8385-44F1-B9FE-D1DC85D09F6C Q50888404-470E6BEA-B3CF-4B38-BBB9-6A6024770D40 Q51327516-64F43205-7695-4268-AAFB-E69D0145214E Q51735768-79E75301-0B9B-4934-985A-8902D1A6E161 Q52371689-F8651988-9D40-42B4-A30C-6CEA944FC7C7 Q57372130-8FFEA065-3644-4B8E-AF2A-165E164DCC05 Q57377323-9775AD3E-55B1-422B-A2E1-93B21EDFDF85 Q57492655-E93AF38A-FEBA-4373-98C4-672A224F9DDB Q58560988-A5211C3D-98CB-4782-8B39-A01CDC6648E4 Q58582293-B0AF27EB-6321-4B5A-8AD9-F00DDEEF4531

P2860

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy

http://www.wikidata.org/entity/Q33687218

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Engineering of hollow mesoporo ...... umor active targeting efficacy

@ast

Engineering of hollow mesoporo ...... umor active targeting efficacy

@en

type

label

Engineering of hollow mesoporo ...... umor active targeting efficacy

@ast

Engineering of hollow mesoporo ...... umor active targeting efficacy

@en

prefLabel

Engineering of hollow mesoporo ...... umor active targeting efficacy

@ast

Engineering of hollow mesoporo ...... umor active targeting efficacy

@en

P1433

Q33687218-FDF6ADE8-76BC-4325-AEC4-873B01AF8FD4

P1476

Q33687218-1AD3094F-E5FA-442E-A1E4-86CD56313492

P2093

Q33687218-690B64F5-8BF6-413F-878E-9B385768EE10

Q33687218-833E08FA-ACCB-4C26-8986-98E3FBCD9B8A

Q33687218-8BAAD634-08CE-426F-823C-A11CCE605790

Q33687218-AA83405D-7B75-4AF7-A386-2698BC51BC36

Q33687218-B91FD192-800A-496E-9378-78111AE65A78

Q33687218-D4B9456D-0699-4DFE-BAFB-5B74A7D6C904

P2860

Q33687218-01D3E061-27BF-4036-8CD6-FCE3CD99D25F

Q33687218-1082F3B7-026C-481F-B572-619B6CF66A2D

Q33687218-230AFEEE-EF3E-4469-A3B5-457FD7B2732D

Q33687218-249F2C9F-6798-4640-AE5E-D9399BA548C4

Q33687218-306D3C29-8912-4D4C-AA04-8DA200936E07

Q33687218-318B0450-6A6F-443B-BE2E-5324E013419C

Q33687218-32DF5ACF-D543-4D4D-BAC8-03E6CB4B333E

Q33687218-354789E4-8183-4E54-BCD8-96F4F03F6B9A

Q33687218-436A94DD-5A8A-4EF0-AA00-13CF91A6EA8A

Q33687218-43D3B3A1-7A28-486D-A863-21AA5B481E22

P2888

Q33687218-76047AFE-9515-46CA-80B8-6E2B0793003A

P304

Q33687218-2A5FE3CA-DF76-445D-B7A8-43FB81606F6B

P31

Q33687218-0F715887-1080-415E-98AE-34C3ED447C32

P356

Q33687218-3F9E9DEB-A239-4751-9596-BA2404AAB0A8

P407

Q33687218-7E39D091-A94D-4435-8186-ECC79D424F7F

P478

Q33687218-E39919AE-B334-465B-9170-226622140700

P50

Q33687218-0C54DD0D-0EA0-4C89-B89B-F5C2EF62E34B

Q33687218-2DAC4510-0E43-4038-9A7B-F6021B2A209C

Q33687218-4DB39565-5640-42E9-BB32-9A8DA39B439D

P577

Q33687218-450FF1F5-51D4-4936-BA5C-28173FD32331

P5875

Q33687218-BEF0743F-8A38-4656-8588-1CDA45D23D32

P6179

Q33687218-C6DA4C8F-2D31-41A1-A831-42336917934A

P698

Q33687218-AD567CA4-85EA-4685-A278-FB47E280174B

P921

Q33687218-B4DEE2A4-14AF-4656-A49D-DF3AF10C91D2

P932

Q33687218-EA5D2D49-15BA-40EB-A935-85F4ED33B66C

P356

P1433

Scientific Reports

P1476

Engineering of hollow mesoporo ...... umor active targeting efficacy

@en

P2093

Charles P Theuer

http://www.w3.org/2001/XMLSchema#string

Feng Chen

http://www.w3.org/2001/XMLSchema#string

Hao Hong

http://www.w3.org/2001/XMLSchema#string

Hector F Valdovinos

http://www.w3.org/2001/XMLSchema#string

Reinier Hernandez

http://www.w3.org/2001/XMLSchema#string

Weibo Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility

Positron emission tomography (PET) imaging with (18)F-based radiotracers

Radiolabelled probes for imaging of atherosclerotic plaques.

Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging.

cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.

Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.

Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light.

Molecular imaging of cancer with positron emission tomography.

Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.

P2888

P304

5080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP05080

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Todd E. Barnhart

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262787302

http://www.w3.org/2001/XMLSchema#string

P6179

1031448156

http://www.w3.org/2001/XMLSchema#string

P698

24875656

http://www.w3.org/2001/XMLSchema#string

P921

P932

4038837

http://www.w3.org/2001/XMLSchema#string